Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara Russell

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Advances in Physiology Education|May 21, 2005
Ethics and scientific publicationDale J Benos, Jorge Fabres, John Farmer, et al.
Journal of Cellular Biochemistry|July 1, 2016
Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug ScreeningTasuku Kiyuna, Takashi Murakami, Yasunori Tome, et al.
Cell Cycle (Georgetown, Tex.)|January 16, 2018
Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse modelKentaro Miyake, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|February 10, 2016
Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) modelTakashi Murakami, Jonathan DeLong, Fritz C Eilber, et al.
Oncotarget|December 29, 2016
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drugTakashi Murakami, Kentaro Igarashi, Kei Kawaguchi, et al.
Oncotarget|June 11, 2016
Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelTakashi Murakami, Arun S Singh, Tasuku Kiyuna, et al.
Tissue & Cell|October 13, 2018
Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP)Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Advances in Physiology Education|May 21, 2005
Ethics and scientific publicationDale J Benos, Jorge Fabres, John Farmer, et al.
Journal of Cellular Biochemistry|July 1, 2016
Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug ScreeningTasuku Kiyuna, Takashi Murakami, Yasunori Tome, et al.
Cell Cycle (Georgetown, Tex.)|January 16, 2018
Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse modelKentaro Miyake, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|February 10, 2016
Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) modelTakashi Murakami, Jonathan DeLong, Fritz C Eilber, et al.
Oncotarget|December 29, 2016
Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drugTakashi Murakami, Kentaro Igarashi, Kei Kawaguchi, et al.
Oncotarget|June 11, 2016
Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelTakashi Murakami, Arun S Singh, Tasuku Kiyuna, et al.
Tissue & Cell|October 13, 2018
Tumor-targeting Salmonella typhimurium A1-R overcomes partial carboplatinum-resistance of a cancer of unknown primary (CUP)Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, et al.
Pageof 2